AAI Vanguard Award Lecture Presenters
Formerly AAI Minority Affairs Committee (MAC) Guest Lecture
Since 2003, the AAI Annual Meeting has featured a scientific lecture sponsored by the AAI Minority Affairs Committee. The lecture series features AAI members who are underrepresented scientists, i.e., those from populations that have been reported by the to be underrepresented in the U.S. biomedical, clinical, behavioral and social sciences research enterprise. Following are past AAI Vanguard (MAC Guest) Lecturers.
Note: lecturers' institutional affiliations reflect their affiliations at the time of their AAI presentation.
2024
Tonya J. Webb, Ph.D.
Univ. of Maryland Sch. of Med.
Modulating NKT cells for cancer immunotherapy
2023
Robert J. Binder, Ph.D.
Univ. of Pittsburgh
Key pathways in immunosurveillance of cancer
2022
Cheri茅 L. Butts, Ph.D.
Biogen
Concept to approved drug: why immunologists are critical when developing new medicines
2021
De’Broski R. Herbert, Ph.D.
Univ. of Pennsylvania Sch. of Vet. Med.
IL-33 regulates the balance between inflammation and immunosuppression
2019
Margaret S. Bynoe, Ph.D.
Cornell University College of Veterinary Medicine
Adenosine receptor axis in blood brain barrier (BBB) permeability regulation
2018
Elina Z煤帽iga, Ph.D.
University of California, San Diego
The art of coexistence: immune adaptations during chronic viral infections
2017
Tyler J. Curiel, M.D., M.P.H.
The University of Texas Health Science Center at San Antonio
Advancing towards optimized cancer immunotherapy
2016
Prosper N. Boyaka, Ph.D.
Ohio State University
Diversity: Lessons from regulation of mucosal immunity by toxins and microbiota
2015
Gabriel N煤帽ez, M.D.
University of Michigan
Linking pathogen virulence, immunity, and the microbiota
2014
Arturo Casadevall, Ph.D.
Albert Einstein College of Medicine, Yeshiva University
A new synthesis for antibody-mediated immunity
2013
Esteban Celis, Ph.D.
Moffitt Cancer Center, University of South Florida
The long road to effective peptide vaccines for cancer: learning from infectious diseases and autoimmunity
2012
Charles E. Egwuagu, M.P.H., Ph.D.
National Eye Institute, National Institutes of Health
Regulation of autoreactive lymphocytes that mediate CNS autoimmune diseases
2011
Olivia M. Martinez, Ph.D.
Stanford School of Medicine
Effects of viral proteins on lymphocyte function in Epstein Barr Virus B cell lymphomas
2010
Albert Zlotnik, Ph.D.
University of California, Irvine
An evolutionary view of chemokines
2009
Emil R. Unanue, M.D.
Washington University School of Medicine
The mysteries of peptide selection by the class II MHC molecules
2008
Juan J. Lafaille, Ph.D.
New York University School of Medicine
Antigen-induced Foxp3+ regulatory T cells
2007
Avery August, Ph.D.
Pennsylvania State University
Tec tyrosine kinase modulation of airway responses
2006
Diana M. Lopez, Ph.D.
University of Miami
A unique mucin immunoenhancing peptide with anti-tumor properties
2005
Juan Carlos Z煤帽iga-Pfl眉cker, Ph.D.
Sunnybrook and Women’s Research Institute, University of Toronto
Becoming a T cell: lineage options and decisions by stem cells
2004
Randy R. Brutkiewicz, Ph.D.
Indiana University School of Medicine
CD1d-mediated antigen presentation to NKT Cells
2003
Richard A. Goldsby, Ph.D.
Amherst College
Human antibody from human artificial chromosome transgenic cloned cattle